Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes
Compelling preclinical studies indicate that low-dose carbon monoxide (CO) abrogates experimental lung fibrosis. We recently reported the results of a multicenter, double-blinded, clinical trial of inhaled CO in patients with idiopathic pulmonary fibrosis (IPF). Identifying no significantly changes...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Text |
Language: | English |
Published: |
Nature Publishing Group UK
2019
|
Subjects: | |
Online Access: | https://pmc.ncbi.nlm.nih.gov/articles/PMC6794274/ https://pubmed.ncbi.nlm.nih.gov/31615996 http://dx.doi.org/10.1038/s41598-019-50585-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|